Biotechnology startup, Bioheaven360 Genotec, has introduced an Al-enabled health platform in collaboration with the All India Institute of Medical Sciences (AIIMS), New Delhi to improve early disease detection and support personalized treatment planning.
According to the company, the platform uses real-time machine learning algorithms to enhance diagnostic accuracy with each new dataset.
It includes extensive phenotyping that captures patients’ data from various sources, including genetic data, lifestyle factors, biomarkers, and environmental inputs.
Key features include cumulative risk assessments, Al-based diagnostic support, and adaptive self-learning capabilities.
Commenting on the development, Dr. Shailendra Vyas, Founder and CEO of Bioheaven360 Genotec, said, “Our goal is to empower individuals with the knowledge and tools they need to make informed decisions about their health and well-being.”
